跳至主要内容
临床试验/NL-OMON26534
NL-OMON26534尚未招募不适用

The Treatment of Breast Cancer with Percutaneous Thermal Ablation: A phase 2 screening trial

Franciscus Gasthuis & Vlietland0 个研究点目标入组 63 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
63

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 2.Age > 45 years and postmenopausal; no menstrual period for at least 12 months.
  • 3.Pathologically confirmed primary invasive breast cancer, unilateral, unifocal
  • 4.A clinical T1N0M0 tumor (= 2cm on US and/or MRI), without distant metastases. The largest dimension measured will be used to determine eligibility.
  • 5.Tumor should be visible on ultrasound.
  • 6.Intraductal component = 25% of the tumor on MRI, complete area including intraductal component should not exceed 2cm.
  • 7.Sufficient knowledge of the Dutch language to complete the questionnaires
  • 8.Written informed consent

排除标准

  • 1.History of invasive breast cancer
  • 2.Pregnant or nursing
  • 3.BRCA 1 or 2 positive
  • 4.Breast augmentation
  • 5.Electrical devices and/or implants
  • 6.Neoadjuvant chemotherapy
  • 7.Triple negative tumors
  • 8.Lobular carcinoma
  • 9.Allergic to local anaesthetics
  • 10.HER2-neu overexpression tumors
  • 11.Bloom-Richardson-Elston (BRE) grade 3 tumors

研究者

相似试验